These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 3330790)

  • 1. Glycine-cysteine substitution at codon 13 of the N-ras proto-oncogene in a human T cell non-Hodgkin's lymphoma.
    Wodnar-Filipowicz A; Senn HP; Jiricny J; Signer E; Moroni C
    Oncogene; 1987; 1(4):457-61. PubMed ID: 3330790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of N-ras induced by ultraviolet irradiation in vitro.
    Van der Lubbe JL; Rosdorff HJ; Bos JL; Van der Eb AJ
    Oncogene Res; 1988; 3(1):9-20. PubMed ID: 3060800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amino-acid substitution at codon 13 of the N-ras oncogene in rectal cancer in a Japanese patient.
    Nitta N; Ochiai M; Nagao M; Sugimura T
    Jpn J Cancer Res; 1987 Jan; 78(1):21-6. PubMed ID: 3102434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in ras oncogenes: rare events in ultraviolet B radiation-induced mouse skin tumorigenesis.
    Khan SG; Mohan RR; Katiyar SK; Wood GS; Bickers DR; Mukhtar H; Agarwal R
    Mol Carcinog; 1996 Feb; 15(2):96-103. PubMed ID: 8599584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transformation of NIH3T3 cells by transfection with UV-irradiated human c-Ha-ras-1 proto-oncogene DNA.
    Pierceall WE; Ananthaswamy HN
    Oncogene; 1991 Nov; 6(11):2085-91. PubMed ID: 1945413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A point mutation at codon 13 of the N-ras oncogene in myelodysplastic syndrome.
    Hirai H; Kobayashi Y; Mano H; Hagiwara K; Maru Y; Omine M; Mizoguchi H; Nishida J; Takaku F
    Nature; 1987 Jun 4-10; 327(6121):430-2. PubMed ID: 3295562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent activation of non-ras transforming sequences in neoplastic Syrian hamster cells initiated with chemical carcinogens.
    Notario V; Castro R; Flessate DM; Doniger J; DiPaolo JA
    Oncogene; 1990 Sep; 5(9):1425-30. PubMed ID: 2216466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preferential and novel activation of H-ras in human bladder carcinomas.
    Visvanathan KV; Pocock RD; Summerhayes IC
    Oncogene Res; 1988; 3(1):77-86. PubMed ID: 3144694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycine to aspartic acid mutations at codon 13 of the c-Ki-ras gene in human gastrointestinal cancers.
    Nagata Y; Abe M; Kobayashi K; Yoshida K; Ishibashi T; Naoe T; Nakayama E; Shiku H
    Cancer Res; 1990 Feb; 50(3):480-2. PubMed ID: 2404571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of stable CD4+ and CD8+ T cell lines from patients immunized with ras oncogene-derived peptides reflecting codon 12 mutations.
    Abrams SI; Khleif SN; Bergmann-Leitner ES; Kantor JA; Chung Y; Hamilton JM; Schlom J
    Cell Immunol; 1997 Dec; 182(2):137-51. PubMed ID: 9514698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RAS mutations in patients following cytotoxic therapy for lymphoma.
    Carter G; Hughes DC; Clark RE; McCormick F; Jacobs A; Whittaker JA; Padua RA
    Oncogene; 1990 Mar; 5(3):411-6. PubMed ID: 2179819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colon carcinoma K-ras 2 oncogene of a familial polyposis coli patient.
    Yuasa Y; Oto M; Sato C; Miyaki M; Iwama T; Tonomura A; Namba M
    Jpn J Cancer Res; 1986 Sep; 77(9):901-7. PubMed ID: 3021699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ras gene activation in a minor proportion of the blast population in acute myeloid leukemia.
    Toksoz D; Farr CJ; Marshall CJ
    Oncogene; 1987; 1(4):409-13. PubMed ID: 3330783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between H-ras p21TLeu61 protein content and tumorigenicity of NIH3T3 cells.
    Bizub D; Blair D; Alvord G; Skalka AM
    Oncogene; 1988 Oct; 3(4):443-8. PubMed ID: 3078952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of activated ras oncogenes in human thyroid carcinomas.
    Suárez HG; Du Villard JA; Caillou B; Schlumberger M; Tubiana M; Parmentier C; Monier R
    Oncogene; 1988 Apr; 2(4):403-6. PubMed ID: 3283656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ras mutations in human leukemia and related disorders.
    Greenberger JS
    Int J Cell Cloning; 1989 Nov; 7(6):343-59. PubMed ID: 2681441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ras oncogene activation in human ovarian carcinoma.
    van 't Veer LJ; Hermens R; van den Berg-Bakker LA; Cheng NC; Fleuren GJ; Bos JL; Cleton FJ; Schrier PI
    Oncogene; 1988 Feb; 2(2):157-65. PubMed ID: 3285294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-H-ras-1 expression in 7,12-dimethyl benzanthracene-induced Balb/c mouse mammary hyperplasias and their tumors.
    Cardiff RD; Gumerlock PH; Soong MM; Dandekar S; Barry PA; Young LJ; Meyers FJ
    Oncogene; 1988 Aug; 3(2):205-13. PubMed ID: 2842717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amino acid substitution at position 13 of the N-ras gene in a non-Hodgkin's lymphoma patient.
    Wodnar-Filipowicz A; Senn HP; Jiricny J; Signer E; Moroni C
    Haematol Blood Transfus; 1987; 31():172-4. PubMed ID: 3327770
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of potential oncogene alterations in the ENU1564 rat mammary tumor model.
    Hal DG; Stoica G
    Anticancer Res; 1994; 14(2A):481-7. PubMed ID: 7912494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.